The protective role of GATA6+ pericardial macrophages in pericardial inflammation

David M Hughes1, Taejoon Won2, Monica V Talor2

  • 1Department of Chemical and Biomolecular Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD 21218, USA.

Iscience
|July 23, 2024
PubMed

Insights

GATA6+ pericardial macrophages prevent pericarditis and reduce inflammatory cell trafficking after myocardial infarction (MI). However, they do not impact myocardial inflammation, fibrosis, or cardiac function post-MI.

Area of Science:

  • Immunology
  • Cardiology
  • Cell Biology

Background:

  • Pericardial macrophages, specifically GATA6-expressing ones, have been implicated in post-myocardial infarction (MI) cardiac repair.
  • Conflicting literature exists regarding their role in myocardial fibrosis and inflammation following MI.

Purpose of the Study:

  • To investigate the specific role of GATA6+ pericardial macrophages in the context of myocardial infarction (MI) and pericarditis.
  • To determine their influence on myocardial inflammation, cardiac fibrosis, and cardiac function.

Main Methods:

  • Utilized mouse models to study GATA6+ pericardial macrophages.
  • Assessed the impact of GATA6+ macrophage absence on IL-33 induced pericarditis, MI, and coxsackievirus-B3 induced myocarditis.
  • Performed in vitro stimulation assays comparing GATA6+ macrophages with bone marrow-derived macrophages.

Main Results:

  • GATA6+ pericardial macrophages are crucial for preventing IL-33 induced pericarditis and limiting inflammatory cell infiltration into the pericardial cavity post-MI.
  • Absence of GATA6+ macrophages did not alter myocardial inflammation, fibrosis, or cardiac function after MI or viral myocarditis.
  • In vitro, GATA6+ macrophages exhibit reduced transcriptional activity and do not upregulate inflammatory markers in fibroblasts.

Conclusions:

  • GATA6+ pericardial macrophages play a vital role in modulating pericardial inflammation.
  • These macrophages do not significantly influence myocardial inflammation or fibrosis development post-MI.